مرکز علوم پایه | The Potential Revolution of Cancer Treatment with CRISPR Technology
پژوهشگران دانشجویان بیماران
EN

Anti-USAG-1 therapy for tooth regeneration through enhanced BMP signaling

 

Abstract

Uterine sensitization-associated gene-1 (USAG-1) deficiency leads to enhanced bone morphogenetic protein (BMP) signaling, leading to supernumerary teeth formation. Furthermore, antibodies interfering with binding of USAG-1 to BMP, but not lipoprotein receptor-related protein 5/6 (LRP5/6), accelerate tooth development. Since USAG-1 inhibits Wnt and BMP signals, the essential factors for tooth development, via direct binding to BMP and Wnt coreceptor LRP5/6, we hypothesized that USAG-1 plays key regulatory roles in suppressing tooth development. However, the involvement of USAG-1 in various types of congenital tooth agenesis remains unknown. Here, we show that blocking USAG-1 function through USAG-1 knockout or anti-USAG-1 antibody administration relieves congenital tooth agenesis caused by various genetic abnormalities in mice. Our results demonstrate that USAG-1 controls the number of teeth by inhibiting development of potential tooth germs in wild-type or mutant mice missing teeth. Anti-USAG-1 antibody administration is, therefore, a promising approach for tooth regeneration therapy.

  • 1402/12/09
  • - تعداد بازدید: 35
  • زمان مطالعه : کمتر از یک دقیقه

The Potential Revolution of Cancer Treatment with CRISPR Technology

.

Abstract: Immuno-oncology (IO) and targeted therapies, such as small molecule inhibitors, have

changed the landscape of cancer treatment and prognosis; however, durable responses have been

difficult to achieve due to tumor heterogeneity, development of drug resistance, and adverse effects that limit dosing and prolonged drug use. To improve upon the current medicinal armamentarium, there is an urgent need for new ways to understand, reverse, and treat carcinogenesis. Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas) 9 is a powerful and efficient tool for genome editing that has shown significant promise for developing new therapeutics. While CRISPR/Cas9 has been successfully used for pre-clinical cancer research, its use in the clinical setting is still in an early stage of development. The purpose of this review is to describe the CRISPR technology and to provide an overview of its current applications and future potential as cancer therapies.

 
  • گروه خبری : اخبار و اطلاعیه ها
  • کد خبری : 76901
کلیدواژه
لیست اخبار

نظرات

0 نظر برای این مطلب وجود دارد

نظر دهید